Floatz logo

Cilostazol

Atherosclerosis

Asan Medical CenterUNKNOWNPhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

17 Active assets in the Atherosclerosis cohort.

Asset / SponsorPhaseRating
Aspirin
Rajaie Cardiovascular Medical and Research Center
Phase 4BBB
Simvastatin
Northern California Institute of Research and Education
Phase 4BBB
Advicor Component Niacin
University of Washington
Phase 4BB
Atorvastatin
Erasmus Medical Center
Phase 4BB
Rosuvastatin
Emory University
Phase 4BB

View all 45 →

Same molecule, other indications

Cilostazol is also rated in:

cerebral infarctionActive
BBB
Indicative · Phase 4
79 / 100
View asset →
transient ischemic attackActive
BBB
Indicative · Phase 4
75 / 100
View asset →
ischemic strokeActive
BBB
Indicative · Phase 4
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →